These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 9418970)

  • 1. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice.
    Forss-Petter S; Werner H; Berger J; Lassmann H; Molzer B; Schwab MH; Bernheimer H; Zimmermann F; Nave KA
    J Neurosci Res; 1997 Dec; 50(5):829-43. PubMed ID: 9418970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
    Mosser J; Douar AM; Sarde CO; Kioschis P; Feil R; Moser H; Poustka AM; Mandel JL; Aubourg P
    Nature; 1993 Feb; 361(6414):726-30. PubMed ID: 8441467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
    Braiterman LT; Watkins PA; Moser AB; Smith KD
    Mol Genet Metab; 1999 Feb; 66(2):91-9. PubMed ID: 10068511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
    Yamada T; Shinnoh N; Kondo A; Uchiyama A; Shimozawa N; Kira J; Kobayashi T
    Cell Biochem Biophys; 2000; 32 Spring():239-46. PubMed ID: 11330052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.
    Feigenbaum V; Lombard-Platet G; Guidoux S; Sarde CO; Mandel JL; Aubourg P
    Am J Hum Genet; 1996 Jun; 58(6):1135-44. PubMed ID: 8651290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    Kemp S; Berger J; Aubourg P
    Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
    Unterrainer G; Molzer B; Forss-Petter S; Berger J
    Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism.
    Kobayashi T; Shinnoh N; Kondo A; Yamada T
    Biochem Biophys Res Commun; 1997 Mar; 232(3):631-6. PubMed ID: 9126326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
    Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
    Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
    Morita M
    Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked adrenoleukodystrophy and primary adrenal insufficiency.
    Cappa M; Todisco T; Bizzarri C
    Front Endocrinol (Lausanne); 2023; 14():1309053. PubMed ID: 38034003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
    Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
    Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
    Takahashi N; Morita M; Imanaka T
    Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full length cDNA cloning, promoter sequence, and genomic organization of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy.
    Holzinger A; Mayerhofer P; Berger J; Lichtner P; Kammerer S; Roscher AA
    Biochem Biophys Res Commun; 1999 May; 258(2):436-42. PubMed ID: 10329405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of ALDP in X-linked adrenoleukodystrophy.
    Watkins PA; Gould SJ; Smith MA; Braiterman LT; Wei HM; Kok F; Moser AB; Moser HW; Smith KD
    Am J Hum Genet; 1995 Aug; 57(2):292-301. PubMed ID: 7668254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
    Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
    Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds.
    Ruiz M; Coll MJ; Pàmpols T; Girós M
    Am J Med Genet; 1998 Apr; 76(5):424-7. PubMed ID: 9556303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
    Singh J; Olle B; Suhail H; Felicella MM; Giri S
    J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.